| Ident. | Authors (with country if any) | Title |
|---|
| 000B83 (2014) |
Stéphanie Bissonnette [Canada] ; Sophie Muratot [Canada] ; Nathalie Vernoux [Canada] ; François Bezeau [Canada] ; Frédéric Calon [Canada] ; Sébastien S. Hebert [Canada] ; Pershia Samadi [Canada] | The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| 000F09 (2013) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tessa Snoeren [Pays-Bas] ; James B. Koprich [Canada] ; Michael P. Hill [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | Use of catechol‐O‐methyltransferase inhibition to minimize L‐3,4‐dihydroxyphenylalanine‐induced dyskinesia in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned macaque |
| 001005 (2013) |
Alexander C. Sutton [États-Unis] ; Wilson Yu [États-Unis] ; Megan E. Calos [États-Unis] ; Lauren E. Mueller [États-Unis] ; Matthew Berk [États-Unis] ; Jenny Shim [États-Unis] ; Eric S. Molho [États-Unis] ; Jonathan M. Brotchie [Canada] ; Peter L. Carlen [Canada] ; Damian S. Shin [États-Unis] | Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat |
| 001348 (2012) |
Andrew Sherwood [États-Unis] ; Marlena Wosiski-Kuhn [États-Unis] ; Truc Nguyen [États-Unis] ; Peter C. Holland [États-Unis] ; Bernard Lakaye [Belgique] ; Antoine Adamantidis [Canada] ; Alexander W. Johnson [États-Unis] | The role of melanin‐concentrating hormone in conditioned reward learning |
| 001406 (2012) |
K. Martinu [Canada] ; C. Degroot [Canada] ; C. Madjar [Canada] ; A. P. Strafella [Canada] ; O. Monchi [Canada] | Levodopa influences striatal activity but does not affect cortical hyper‐activity in Parkinson’s disease |
| 001809 (2011) |
Masayuki Watanabe [Japon, Canada] ; Douglas P. Munoz [Canada] | Probing basal ganglia functions by saccade eye movements |
| 001B10 (2010) |
Yanwei Xi [Canada] ; Joel Ryan [Canada] ; Sandra Noble [Canada] ; Man Yu [Canada] ; Ayse E. Yilbas [Canada] ; Marc Ekker [Canada] | Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function |
| 001C24 (2010) |
Anna Dvorkin [Canada] ; Charmaine Silva [Canada] ; Thomas Mcmurran [Canada] ; Liane Bisnaire [Canada] ; Jane Foster [Canada] ; Henry Szechtman [Canada] | Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex |
| 001C34 (2010) |
Elena-Dana Baraboi [Canada] ; Chantal Michel [Canada] ; Pauline Smith [Canada] ; Karen Thibaudeau [Canada] ; Alastair V. Ferguson [Canada] ; Denis Richard [Canada] | Effects of albumin‐conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve |
| 001C45 (2010) |
Martin Parent [Canada] ; Marie-Josée Wallman [Canada] ; Laurent Descarries [Canada] | Distribution and ultrastructural features of the serotonin innervation in rat and squirrel monkey subthalamic nucleus |
| 001C48 (2010) |
Clement Hamani [Canada] ; José N. N Brega [Canada] | Deep brain stimulation in clinical trials and animal models of depression |
| 002001 (2009) |
Na K. Kim [Corée du Sud] ; Byung H. Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian J. Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae-Ho Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung C. Park [Corée du Sud] ; So R. Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
| 002039 (2009) |
Félix-Etienne François-Brosseau [Canada] ; Kristina Martinu [Canada] ; Antonio P. Strafella [Canada] ; Michael Petrides [Canada] ; France Simard [Canada] ; Oury Monchi [Canada] | Basal ganglia and frontal involvement in self‐generated and externally‐triggered finger movements in the dominant and non‐dominant hand |
| 002270 (2008) |
Lori K. Smith [Canada] ; Nafisa M. Jadavji [Canada] ; Keri L. Colwell [Canada] ; S. Katrina Perehudoff [Canada] ; Gerlinde A. Metz [Canada] | Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease |
| 002278 (2008) |
Laurie H. L. Sellings [Canada] ; Golriz Baharnouri [Canada] ; Lindsey E. Mcquade [Canada] ; Paul B. S. Clarke [Canada] | Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens |
| 002340 (2008) |
Darcy Litteljohn [Canada] ; Emily N. Mangano [Canada] ; Shawn Hayley [Canada] | Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice |
| 002358 (2008) |
M. Quinn [Canada] ; K. Mukhida [Canada] ; D. Sadi [Canada] ; M. Hong [Canada] ; I. Mendez | Adjunctive use of the non‐ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease |
| 002535 (2007) |
Omar A. Gharbawie [Canada] ; Jenni M. Karl [Canada] ; Ian Q. Whishaw [Canada] | Recovery of skilled reaching following motor cortex stroke: do residual corticofugal fibers mediate compensatory recovery? |
| 002550 (2007) |
Mariam Alaverdashvili [Canada] ; Diana H. Lim [Canada] ; Ian Q. Whishaw [Canada] | No improvement by amphetamine on learned non‐use, attempts, success or movement in skilled reaching by the rat after motor cortex stroke |
| 002575 (2007) |
Gonzalo Arboleda [Royaume-Uni, Colombie] ; Tze-Jen Huang [Royaume-Uni] ; Catherine Waters [Royaume-Uni] ; Alex Verkhratsky [Royaume-Uni] ; Paul Fernyhough [Royaume-Uni, Canada] ; Rosemary M. Gibson [Royaume-Uni] | Insulin‐like growth factor‐1‐dependent maintenance of neuronal metabolism through the phosphatidylinositol 3‐kinase–Akt pathway is inhibited by C2‐ceramide in CAD cells |
| 002834 (2006) |
Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada] | Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice |
